C2C: COMBINE-2 for Cabotegravir+Rilpivirine LA Regimen - A Prospective Cohort Study to Monitor Effectiveness, Adherence and Resistance (215160)

26/08/2021
04/07/2025
EU PAS number:
EUPAS42609
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-215160-protocol-orig-redact

English (1.47 MB - PDF) View document
Study results
Study report
Other information